Institute of Medicine recommendations for the prevention and control of hepatitis B and C

Authors

  • Abigail E. Mitchell,

    Corresponding author
    1. Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies, Washington, DC
    • Institute of Medicine, Keck 858, 500 Fifth Street NW, Washington, DC 20001
    Search for more papers by this author
    • fax: 202-334-2939

  • Heather M. Colvin,

    1. Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies, Washington, DC
    Search for more papers by this author
  • R. Palmer Beasley

    1. Division of Epidemiology and Disease Control, University of Texas School of Public Health, Houston, Texas
    Search for more papers by this author

  • The Institute of Medicine study was funded by the Centers for Disease Control and Prevention, the Department of Health and Human Services' Office of Minority Health, the Department of Veterans Affairs, and the National Viral Hepatitis Roundtable.

  • Potential conflict of interest: Nothing to report.

Abstract

Despite federal, state, and local public health efforts to prevent and control hepatitis B virus (HBV) and hepatitis C virus (HCV) infections, these diseases remain serious health problems in the United States. About 1%-2% of the U.S. population has chronic HBV or HCV infections, and each year about 15,000 people die from liver cancer or liver disease related to these preventable infections. The Institute of Medicine formed an expert committee to determine ways to reduce new HBV and HCV infections and the morbidity and mortality related to chronic viral hepatitis and released its findings in a report. The major factor found to impede current efforts to prevent and control HBV and HCV is lack of knowledge and awareness about these diseases among healthcare and social-service providers, members of the public, and policy makers. Because the extent and seriousness of this public health problem is not appreciated, inadequate resources are being allocated to prevention, control, and surveillance programs. This situation has led to continued transmission of HBV and HCV and inadequate identification of and medical management for chronically infected people. Conclusion: To address the situation, the Institute of Medicine report makes recommendations in four areas: improved surveillance for HBV and HCV; improved knowledge and awareness among healthcare and social-service providers and the public, especially at-risk people; improved HBV vaccine coverage; and improved viral hepatitis services and access to those services. HEPATOLOGY, 2010

Ancillary